Non-Hodgkin lymphoma von Armitage, James O, Prof, Gascoyne, Randy D, Prof, Lunning, Matthew A, DO, Cavalli, Franco, Prof

Volltext

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma von Ma, Man Chun John, Tadros, Saber, Bouska, Alyssa, Heavican, Tayla, Yang, Haopeng, Deng, Qing, Moore, Dalia, Akhter, Ariz, Hartert, Keenan, Jain, Neeraj, Showell, Jordan, Ghosh, Sreejoyee, Street, Lesley, Davidson, Marta, Carey, Christopher, Tobin, Joshua, Perumal, Deepak, Vose, Julie M, Lunning, Matthew A, Sohani, Aliyah R, Chen, Benjamin J, Buckley, Shannon, Nastoupil, Loretta J, Davis, R Eric, Westin, Jason R, Fowler, Nathan H, Parekh, Samir, Gandhi, Maher, Neelapu, Sattva, Stewart, Douglas, Bhalla, Kapil, Iqbal, Javeed, Greiner, Timothy, Rodig, Scott J, Mansoor, Adnan, Green, Michael R

Volltext

MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications von Bi, Chengfeng, Huang, Yuhua, Ali, Roshia, Wang, Fang, Yang, Xia, Bouska, Alyssa, Xu, Lu, Hao, Xinbao, Lunning, Matthew A, Chan, Wing C, Iqbal, Javeed, Weisenburger, Dennis D, Vose, Julie M, Fu, Kai

Volltext

CAR T‐Cell Therapy in Hematologic Malignancies: A Voyage in Progress von Holstein, Sarah A., Lunning, Matthew A.

Volltext

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma von Lunning, Matthew A., Vose, Julie M.

Volltext

Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study von Rezazadeh, Alexandra, Szabo, Aniko, Khurana, Arushi, Inwards, David J, Lunning, Matthew A, Bartlett, Nancy L, Caimi, Paolo F, Rodgers, Thomas D, Barr, Paul M, Chowdhury, Sayan Mullick, Epperla, Narendranath, Mendries, Hiruni, Hill, Brian T, Oh, Timothy S, Karmali, Reem, Chang, Julie E, Goyal, Gaurav, Parsons, Benjamin M, Isaac, Krista M, Portell, Craig A, Monahan, Kathleen, Siker, Malika, King, David M, Fenske, Timothy S

Volltext

Strategies for Relapsed Peripheral T-Cell Lymphoma: The Tail That Wags the Curve von LUNNING, Matthew A, MOSKOWITZ, Alison J, HORWITZ, Steven

Volltext

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study von Abramson, Jeremy S, Palomba, M Lia, Gordon, Leo I, Lunning, Matthew A, Wang, Michael, Arnason, Jon, Mehta, Amitkumar, Purev, Enkhtsetseg, Maloney, David G, Andreadis, Charalambos, Sehgal, Alison, Solomon, Scott R, Ghosh, Nilanjan, Albertson, Tina M, Garcia, Jacob, Kostic, Ana, Mallaney, Mary, Ogasawara, Ken, Newhall, Kathryn, Kim, Yeonhee, Li, Daniel, Siddiqi, Tanya

Volltext

Relapsed or Refractory Diffuse Large B-Cell Lymphoma: “Dazed and Confused” von Kesireddy, Meghana, Lunning, Matthew A

Volltext

Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: A single-center, retrospective study von Marchetti, Michael A., MD, Pulitzer, Melissa P., MD, Myskowski, Patricia L., MD, Dusza, Stephen W., DrPH, Lunning, Matthew A., DO, Horwitz, Steven M., MD, Moskowitz, Alison J., MD, Querfeld, Christiane, MD, PhD

Volltext

Rituximab maintenance therapy in diffuse large B-cell lymphoma: is XY the most important variable? von Lunning, Matthew A, Armitage, James O

Volltext

Checkpoint inhibition in ENKTL: Kno_le_ge G_ps von Elnair, Radowan, Lunning, Matthew A.

Volltext

How I treat the peripheral T-cell lymphomas von Moskowitz, Alison J., Lunning, Matthew A., Horwitz, Steven M.

Volltext

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma von Odejide, Oreofe, Weigert, Oliver, Lane, Andrew A., Toscano, Dan, Lunning, Matthew A., Kopp, Nadja, Kim, Sunhee, van Bodegom, Diederik, Bolla, Sudha, Schatz, Jonathan H., Teruya-Feldstein, Julie, Hochberg, Ephraim, Louissaint, Abner, Dorfman, David, Stevenson, Kristen, Rodig, Scott J., Piccaluga, Pier Paolo, Jacobsen, Eric, Pileri, Stefano A., Harris, Nancy L., Ferrero, Simone, Inghirami, Giorgio, Horwitz, Steven M., Weinstock, David M.

Volltext

Do you know TAFRO? von Lunning, Matthew A., Armitage, James O.

Volltext

Treatment of Peripheral T-Cell Lymphoma: Many Shades of Gray von Lunning, Matthew A

Volltext

Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia von DOUER, Dan, ALDOSS, Ibrahim, PULLARKAT, Vinod, MOHRBACHER, Ann M, LUNNING, Matthew A, BURKE, Patrick W, RAMEZANI, Laleh, MARK, Lisa, VRONA, Janice, PARK, Jae H, TALLMAN, Martin S, AVRAMIS, Vassilios I

Volltext

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma von Jain, N, Hartert, K, Tadros, S, Fiskus, W, Havranek, O, Ma, MCJ, Bouska, A, Heavican, T, Kumar, D, Deng, Q, Moore, D, Pak, C, Liu, CL, Gentles, AJ, Hartmann, E, Kridel, R, Smedby, KE, Juliusson, G, Rosenquist, R, Gascoyne, RD, Rosenwald, A, Giancotti, F, Neelapu, SS, Westin, J, Vose, JM, Lunning, MA, Greiner, T, Rodig, S, Iqbal, J, Alizadeh, AA, Davis, RE, Bhalla, K, Green, MR

Volltext

Management of indolent lymphoma: Where are we now and where are we going von Lunning, Matthew A, Vose, Julie M

Volltext

Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II–IV peripheral T‐cell lymphoma von Stuver, Robert, Horwitz, Steven M., Advani, Ranjana H., Vose, Julie M., Lee, Hun Ju, Mehta‐Shah, Neha, Zain, Jasmine M., Haverkos, Bradley, Lechowicz, Mary Jo, Moskowitz, Alison J., Pham, Luu Q., Leyden, Elizabeth, Ansell, Stephen M., Lunning, Matthew A.

Volltext